NCT00010010View on ClinicalTrials.gov

Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2000

Primary Completion Date

May 31, 2001

Conditions
Breast Cancer
Interventions
DRUG

exemestane

DRUG

goserelin acetate

Trial Locations (1)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00010010 - Exemestane Plus Goserelin in Treating Premenopausal Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter